Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

This Just In: Upgrades and Downgrades – Molycorp Inc (MCP), Silver Wheaton Corp. (SLW)

Page 1 of 2

At The Motley Fool, we poke plenty of fun at Wall Street analysts and their endless cycle of upgrades, downgrades, and “initiating coverage at neutral.” Today, we’ll show you whether those bigwigs actually know what they’re talking about. To help, we’ve enlisted Motley Fool CAPS to track the long-term performance of Wall Street’s best and worst.

A good day to be a miner
Yesterday was a good day to own a mining company, or invest in mining stocks, as Wall Street analysts continued to sing the praises (“Hi-ho, hi-ho, it’s off to buy we go!”) of just about everyone who’s digging anything valuable out of the earth. Earlier this week, we saw JPMorgan begin the trend with an upgrade of Stillwater Mining Company (NYSE:SWC) to overweight. This was quite the contrarian call, given that most analysts on Wall Street still expect to see years of declining earnings at the platinum miner. Yesterday, though, that trickle of interest turned into a torrent.

Molycorp Inc (NYSE:MCP)Whether it was rare-earth-element miner Molycorp Inc (NYSE:MCP), truly rare diamond digger Harry Winston Diamond Corporation (USA) (NYSE:HWD), or even less valuable metals miner Silver Wheaton Corp. (USA) (NYSE:SLW), the Street’s enthusiasm for shiny rocks continued unabated. But is it justified?

Let’s find out, beginning with…

Harry Winston Diamond Corporation (USA) (NYSE:HWD)

Fresh off its deal to sell its luxury-branded diamond jewelry business to Swatch last month, Harry Winston won an upgrade to outperform from analysts at Scotia Capital Thursday. At first glance, this upgrade seems a bit strange. After all, at 34.5 times trailing earnings, Harry’s stock hardly looks like a bargain — but two factors argue that this stock may be a diamond in the rough. (Sorry. Had to say it. The Financial Writer’s Code of Conduct calls for at least one bad pun per column).

First off, analysts have Harry pegged for 36% annualized profits growth over the next five years, which is fast enough growth to make even a 34.5 P/E look cheap. More importantly, though, Harry’s deal with Swatch calls for the company to collect $750 million from the sale of its retail division, and offload $250 million in debt as well. That’s enough money to swing Harry’s balance sheet from a $228 million net-debt position to more than $750 million net cash — and turn Harry into a company with about $500 million enterprise value.

Given that last year, Harry’s mining division produced a net profit of about $35 million, the stock appears to be trading for less than a 15 P/E based on its post-retail unit-sale valuation. Assuming its growth rate can hold up without retail to support it, the stock looks cheap to me.

Molycorp Inc (NYSE:MCP)

Next up: Molycorp. Yesterday, JPMorgan Chase — which referred to as a “noted bear” on Molycorp — switched gears on the stock and pulled its underperform rating. Citing Moly’s recent stock-and-debt offering as removing “near-term risk,” the analyst upgraded the stock to neutral, eliciting “cheers” (again, according to StreetInsider) from investors.

And yet, a neutral rating does not a buy-argument make, and if truth be told, even JP still has doubts about the stock. Priced at two times sales, and infinity times the profits it isn’t earning, Molycorp remains one seriously risky stock. It’s drowning in debt already, with nearly $800 million more debt than cash on its balance sheet, and adding more debt by the day, with free cash flow now standing at negative $819 million.

While I suppose it’s possible that the company will ultimately pull out of its funk, get more mines on line, and begin earning a profit for its shareholders, Moly’s history of incessant cash burn (it’s literally never generated real free cash flow from its business, despite reporting a “GAAP” profit in 2011) is a big, bright red flag waving over the stock. Long story short, I’d be more inclined to short it than to go long.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!